|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Arthritis was induced in DBA/1 mice by collagen type II in complete Freund's adjuvant and the animals were treated with Dexamethasone (Dexa) (0.25 mg/kg/day) with or without HNG (100 μg/kg/day) for 14 days.
|
31172921 |
2020 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We infected Ts and then induced CIA in STAT6KO DBA/1 mice, comparing the disease progression with that in wild-type (WT) DBA/1 mice, Ts significantly mitigated arthritis in WT mice, in addition to the impairment of anti-type II collagen (IIC) IgG production in a subclass-independent manner.
|
31605645 |
2020 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Interestingly, NSC23766 alleviated the process of collagen-induced arthritis of DBA mice in vivo, including the reduced hind paw thickness and ankle stiffness, the reduction of arthritic scores and incidence of arthritis.
|
30880553 |
2020 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis.
|
30959558 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Alpha-mangostin: Anti-inflammatory and antioxidant effects on established collagen-induced arthritis in DBA/1J mice.
|
30557668 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Exposure of leukocytes from type II collagen-immunized DBA/1 mice to ibudilast in vitro attenuated their ability to adoptively transfer arthritis to DBA/1J-Prkdc<sup>SCID</sup> mice, providing evidence of an immunomodulatory effect.
|
30474934 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In vitro and in vivo screening of an Food and Drug Administration (FDA)-approved drug library; in vitro and in vivo assays for examining the blockade of TNF actions by fexofenadine: assays for defining the anti-inflammatory activity of fexofenadine using TNF-α transgenic (TNF-tg) mice and collagen-induced arthritis in DBA/1 mice.
|
31302596 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
A mouse model of DBA/1JJmsSlc collagen-induced arthritis was treated with Th2 or Th17 cell inhibitor, and transepidermal water loss (TEWL) and the expression of markers associated with allergic reaction and inflammation were evaluated.
|
30828078 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using the models of collagen-induced arthritis (CIA), antigen-induced arthritis (AIA), and K/BxN serum-transfer-induced arthritis (STIA), we determined the effectiveness of WEHI-112 at inhibiting clinical and histologic features of arthritis in C57BL/6 and DBA/1 mice.
|
30009417 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
F1 (DBA/1 x B10.Q) mice were orally inoculated with P. gingivalis before collagen-induced arthritis was provoked.
|
31148565 |
2019 |
|
Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Using a panel of immunohistochemical and immunofluorescence analyses in a CIA model established in 18 DBA/1J mice, we demonstrated that IL-35 promotes synoviocyte apoptosis and alternative activation of macrophages to alleviate arthritis in vivo.
|
30834683 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
DBA/1 mice were immunized with bovine type II collagen to induce arthritis, and then treated with anti-mFKN mAb.
|
30079992 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
<i>Lactobacillus fermentum</i> PC1 has the Capacity to Attenuate Joint Inflammation in Collagen-Induced Arthritis in DBA/1 Mice.
|
30959746 |
2019 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
For the in vivo study, collagen-induced arthritis (CIA) was developed in DBA/1 mice, and the clinical score for arthritis was measured regularly.
|
29326355 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
DBA/1JJmsSlc control mice (n = 5) and DBA/1JJmsSlc collagen-induced arthritis mouse model (arthritis mice; n = 5) were used.
|
28573874 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated the improvement of astilbin and low-dose MTX combination on collagen-induced arthritis in DBA/1J mice.
|
29410374 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Collagen-induced arthritis was induced in DBA1/J mice.
|
29708588 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Depleting the carboxy-terminus of human Wnt5a attenuates collagen-induced arthritis in DBA/1 mice.
|
30213634 |
2018 |
|
Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The results showed that LCA significantly suppressed arthritis via the activation of SQSTM1 (p62)/nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling in the collagen-induced arthritis (CIA) model of DBA mice.
|
29233793 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Exogenous GH administration in arthritic DBA/1J mice reduced the severity of established CIA as well as the inflammatory environment, which also shows a GH effect on arthritis progression.
|
29887869 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Periodontitis was induced via oral gavage in SKG, DBA/1 and F1 (DBA/1 × B10.Q) mice and collagen-induced arthritis was provoked via immunization and boost with bovine collagen type II.
|
30310087 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mice with DBA/1JJmsSlc collagen-induced arthritis were treated with inhibitors or neutralizing antibodies.
|
29698950 |
2018 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have previously reported that treatment with HLA-G1 and HLA-G2 ameliorates the joint swelling associated with collagen-induced arthritis of DBA/1 mice, an animal model for rheumatoid arthritis.
|
28675838 |
2017 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Arthritis was induced in DBA/1 mice with bovine collagen type II and complete Freund's adjuvant.
|
28522406 |
2017 |
|
Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We performed longitudinal in vivo imaging with [<sup>18</sup>F]-fluoride PET/CT before and after experimental arthritis onset for diseased and control DBA/1 mice and assessed arthritis progression by clinical scoring, tracer uptake studies and bone volume as well as surface roughness measurements.
|
28533505 |
2017 |